Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
17 September 2018 Photo Charl Devenish
Science Its a girl thing
Innocensia Mangoato’s research on using cannabis to reverse anticancer drug resistance has been awarded in the prestigious Women in Science Awards.

“There’s this misconception among young people that science is difficult and that it’s somehow a man’s domain,” says Innocensia Mangoato, Masters student in Pharmacology, who has just been awarded in the prestigious Women in Science Awards by the Department of Science and Technology.

Cannabis research

Innocensia won in the Master’s Degree category for her research on the use of cannabis in reversing anticancer drug resistance. Her department had to apply for a special permit to grow cannabis for research and medicinal purposes.

“Her findings have already indicated a promising reversal of resistance to drugs in a variety of cancers. We plan to explore these results further in a possible PhD,” says her study leader, Prof Motlalepula Matsabisa.

Innocensia says she’s always had an interest in science, and initially wanted to study medicine. She ended up doing a BSc in Physiology and Genetics.

She hopes that her research will help government to develop a policy around the use of cannabis for medicinal purposes which could ultimately lead to developing cancer treatment with fewer side-effects.

Female mentors

“My mentor during my Honours studies was Dr Makhotso Lekhoa. Her passion for her field and her patience in conveying it to others really inspired me. We have some very powerful women in our Pharmacology Department,” says Innocensia.

Passion for science 

“You know you’re passionate about your work when you find yourself going to the lab on Sunday afternoons!” she says. “I’m happy that I can be contributing to the knowledge production on this campus. And maybe one day I can be a mentor to other girls with that same passion for science.”

News Archive

Kovsie gold medalist defeats Olympic champion
2015-07-07

Wayde van Niekerk and Kirani James
Photo: deuxHD DIRECT

Once again, Kovsie Wayde van Niekerk has made history by defeating the London 2012 Olympic Games champion, Kirani James, of Grenada in the Caribbean. 

On 4 July 2015, he surged 0.79 seconds ahead of Kirani in his  number five lane, becoming the first African to cover 400m in less than 44 seconds. The Kovsie student won the race at 43.96, occupying 10th place on the International Association of Athletics Federations (IAAF) Diamond League all-time list.

Kovsies were still celebrating the gold medalist’s South African record-setting time of 44.24 on 13 June 2015, when he dominated the Diamond League meeting. At the previous race in New York, Van Niekerk improved on his own national record of 44.38. With an impressive dash to the finish line at that particular event, he surpassed Christopher Brown’s 400m record.

In addition to the country’s record, Van Niekerk made his name as one of the continent’s record-breakers. On 7 June 2015, he broke the 1986 African 300m record. Van Niekerk replaced Ivorian Gabriel Tiacoh’s best time of 31.74 with a 31.63 championship win at the Birmingham Diamond League meeting.  Simultaneously, he bettered Morné Nagel’s 2006 South African national record.

Following this outstanding performance, he was positioned in 10th place on the world list in the men’s 300m.

Currently, Van Niekerk is preparing for the 14 July 2015 Diamond League meeting to be held in Lucerne, Switzerland. His last Lucerne race was in 2014 where he clocked 20.19 in the men’s 200m. Based on his recent successes, Van Niekerk seems to have launched himself on a history-making spree, and may well set a new personal best.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept